Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Teladoc ( (TDOC) ) is now available.
On December 11, 2025, J. Eric Evans announced his decision to retire from Teladoc Health’s Board of Directors, effective after the 2026 Annual Meeting of Stockholders. Mr. Evans, who has served since 2023, is stepping down for personal reasons, with no disagreements with the company, marking a leadership transition for Teladoc.
The most recent analyst rating on (TDOC) stock is a Hold with a $8.50 price target. To see the full list of analyst forecasts on Teladoc stock, see the TDOC Stock Forecast page.
Spark’s Take on TDOC Stock
According to Spark, TipRanks’ AI Analyst, TDOC is a Neutral.
Teladoc’s overall stock score reflects significant financial and technical challenges. The company’s persistent losses and negative valuation metrics weigh heavily on the score. While the earnings call provided some positive insights, such as exceeding revenue guidance and international growth, these are overshadowed by the bearish technical indicators and ongoing operational inefficiencies.
To see Spark’s full report on TDOC stock, click here.
More about Teladoc
Teladoc Health, Inc. operates in the telemedicine industry, providing virtual healthcare services and solutions to connect patients with healthcare professionals remotely. The company focuses on delivering a range of medical services through digital platforms, catering to a broad market seeking convenient and accessible healthcare options.
Average Trading Volume: 7,580,891
Technical Sentiment Signal: Strong Sell
Current Market Cap: $1.34B
For detailed information about TDOC stock, go to TipRanks’ Stock Analysis page.